Align Technology (ALGN)
Health Care · Medical Devices & Supplies · NASDAQ
Align Technology provides digital dental solutions including the Invisalign system and iTero intraoral scanners to transform orthodontic and restorative care.
What Align Technology does
Align Technology is a global medical device company that designs, manufactures, and markets the Invisalign system of clear aligners and iTero intraoral scanners and services. Its solutions are used by orthodontists and general practitioner dentists to transform and improve the delivery of dental care through digital workflows. The company focuses on the orthodontic and restorative dentistry markets.
Themes: digital dentistry, orthodontics, medical technology, aesthetic dentistry
Fundamentals
- Price$162.55 as of 2026-08-21 close
- Market cap$11.5B as of 2026-08-21
- 1-year return+15.6% 2025-08-21 close $140.67 → 2026-08-21 close $162.55
- P/E29.86 as of 2026-08-24
- Net margin+10.0% as of 2026-08-24
- Gross margin+69.0% as of 2026-08-24
- ROE+10.1% as of 2026-08-24
- Debt / equity0.00 as of 2026-08-24
- Revenue growth (YoY)+4.4% as of 2026-08-24
- Revenue CAGR (3y)+2.6% SEC XBRL
- Beta1.66 as of 2026-08-24
- Last reported earnings2026-07-29 SEC EDGAR Form 8-K (Item 2.02)
How ALGN compares in its sector
- price-to-earnings ratiomiddle range 203 covered Health Care peers, as of 2026-08-24
- net profit margintop 25% 504 covered Health Care peers, as of 2026-08-24
- operating margintop 25% 504 covered Health Care peers, as of 2026-08-24
- gross marginmiddle range 384 covered Health Care peers, as of 2026-08-24
- return on equitytop 25% 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)top 25% 493 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
ALGN is not currently in any published Top 10 list. Its scores are below.
Long-term score
Not scored for the long-term list: no shareholder return data.
Short-term score
47.6 #943 of 1,704 scored · #167 of 240 in Health Care
Volume and participation 85th: trading volume is about normal versus its 30-day average; setup 63rd: over the past year its closes ranged, and it has retraced around half of its move over the past year — 48% of it; weakest is trend 31st: the price is 5% below the average price paid over the period covered, so the typical buyer over that stretch is under water.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
How Align Technology looks technically
Align Technology (ALGN) is trading 3.8% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed above its 200-day average about 137 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 11, below the 25 that marks a real trend), though sellers have been pushing harder than buyers lately — pressure, not a trend. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 41, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 4 trading days ago (its momentum flipped negative). It made a new 20-day low about 2 trading days ago. It is 18.8% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 3.8% below its 200-day average, the long-term trend line — a long-term downtrend | -3.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $174.59 | $174.59 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $168.93 | $168.93 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 7 calendar days ago — the swings before that are what the structure reading is measured on | 7 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes above 182.2. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible downward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 137 trading days ago — a "golden cross", a bullish long-term signal | 137 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 11, below the 25 that marks a real trend), though sellers have been pushing harder than buyers lately — pressure, not a trend | 11.4 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 41, neither overbought (above 70) nor oversold (below 30) | 41.3 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($157.34 to $182.20) — its "stochastic" reading is 21 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 21.0 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 4 trading days ago (its momentum flipped negative) | 4 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $200.25 | $200.25 |
|---|---|---|
| From the 52-week high | it is 18.8% below its 52-week high (its highest price of the past year) | -18.8% |
| Above the 52-week low | it is 33.2% above its 52-week low (its lowest price of the past year) | +33.2% |
| Below the 52-week high | it is 18.8% below its highest point of the past year | 18.8% |
| Since a 20-day breakout | it made a new 20-day low about 2 trading days ago | 2 sessions |
| Since a 55-day breakout | it made a new 55-day low about 2 trading days ago | 2 sessions |
| All-time high | its highest closing price on record is $737.45 (set on 2021-09-23) | $737.45 |
| Given back of the 52-week move | over the past year its closes ranged ($124.88 to $197.51), and it has given back around half of its rise from last year’s low — 48% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $150.30 to $152.62. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 48.1% |
| From the all-time high | it is 78.0% below its all-time high | -78.0% |
| Nearest price level | it is trading 1.0% below a resistance level at $164.16 — a price it turned at five times since 2026-01-20, most recently on 2026-07-31. Since 2024-08-21 it has 4 such levels below the current price and 12 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +1.0% |
| All-time low | its lowest closing price on record is $4.88 (set on 2008-10-24) | $4.88 |
| Above the all-time low | it is 3230.9% above its all-time low | +3,231% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 41st percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $6.91 between its high and its low — about 4.3% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $6.91 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $160.69 and $182.73 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $160.69 – $171.71 – $182.73 |
| Typical daily range (% of price) | its price moves about 4.3% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 4.3% |
| Stretch from the 200-day average | it is trading 0.9 daily ranges below its 200-day average price (3.8% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 0.9 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.22× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a hammer | 7 sessions ago, after a stretch of decline, it sold off hard during the session and then closed back near its high — a "hammer", the long lower wick showing the drop was bought back before the close | 7 sessions ago |
|---|
Price gaps
1
| Gap at the open | it opened on 2026-08-21 0.5% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.5% |
|---|
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 10.8 percentage points (the stock lost 8.4% while the market gained 2.3%) | -10.8% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 3.4 percentage points (the stock lost 0.3% while the market gained 3.1%) | -3.4% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 25.5 percentage points (the stock lost 14.5% while the market gained 11.1%) | -25.5% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 4.9 percentage points (the stock gained 15.6% while the market gained 20.5%) | -4.9% |
Signal agreement
2
| Bullish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day — these describe past price behaviour, not a forecast | 1 of 9 |
|---|---|---|
| Bearish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bearish state: trading below its 200-day average, a fresh 20-day low, MACD momentum is negative, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 5.1% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 5.3% of the share price. | -5.1% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 7% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $174.83 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | -7.0% |
|---|---|---|
| Vs the average paid since it last reported | the price is 5% below the average price paid since it last reported on 2026-07-29 (its 8-K), so the typical buyer over that stretch is under water. That average is $171.89 — a volume-weighted average of daily closes over 18 sessions, not a true tick-by-tick VWAP. | -5.4% |
Price levels it has turned at before
ALGN last closed at $162.55 on 2026-08-21. Since 2024-08-21 it has turned at 4 prices below its last close and 12 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $164.16 | Resistance | 1.0% above the last close | turned there five times · 2026-01-20 to 2026-07-31 |
| $167.72 | Resistance | 3.2% above the last close | turned there four times · 2025-05-07 to 2026-04-30 |
| $154.78 | Support | 4.8% below the last close | turned there twice · 2026-01-02 to 2026-02-03 |
| $173.65 | Resistance | 6.8% above the last close | turned there five times · 2025-03-24 to 2026-02-23 |
| $150.86 | Support | 7.2% below the last close | turned there three times · 2025-08-22 to 2026-05-20 |
| $141.06 | Support | 13.2% below the last close | turned there twice · 2025-04-08 to 2025-09-09 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes above $182.20.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $139.76 and $155.97 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close above $182.20.
This reading has stood for 1 trading day, since 2026-08-21.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Broke down to a new 20-day low · MACD just crossed bearish (12/26/9) · trendless / choppy (low ADX) · lagging the market · Under water since its last earnings report (below the anchored VWAP) | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.94 mean, 1=Strong Buy…5=Strong Sell) — 15 analysts
- Mean price target$208.60 range $170.00 – $240.00; median $209.00
Analyst estimates, as of 2026-08-24. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for ALGN
- Consensus EPS estimate$2.79 next reporting period, as of 2026-08-24
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependence on demand for elective dental procedures which can be sensitive to macroeconomic conditions and consumer spending.","Significant competition from established and emerging dental device manufacturers.","Risks associated with international operations, including regulatory compliance, currency fluctuations, and geopolitical tensions."]
What changed in the latest 10-Q
AI-assisted comparison of ALGN's 10-Q filed 2026-05-06 against the prior one filed 2025-11-05.
Management's Discussion & Analysis (MD&A)
- Added:
- Added reference to 'recent U.S. Supreme Court decision on the constitutionality of tariffs' in forward-looking statements (filed 2026-05-06)
- Added section 'Our Strategic Growth Drivers' as subsection before 'Trends and Uncertainties' (filed 2026-05-06)
- Added explicit statement about striving to help doctor customers move practices forward by connecting with new patients and providing digital solutions (filed 2026-05-06)
- Updated Annual Report reference from 'year ended December 31, 2024 as filed with the Securities and Exchange Commission (the "SEC") on February 28, 2025' to 'year ended December 31, 2025 as filed with the Securities and Exchange Commission (the "SEC") on February 27, 2026' (filed 2026-05-06)
- Removed:
- Removed 'or trade wars' from macroeconomic conditions description in forward-looking statements (filed 2025-11-05)
- Removed reference to 'including military actions in Israel and increased geopolitical tensions involving Taiwan and the South China Sea' and 'particularly in Israel and Russia' from geopolitical tensions discussion (filed 2025-11-05)
- Removed paragraph about restructuring plan: 'our ability to implement and realize the anticipated benefits currently expected from our restructuring plan initiated in the third quarter of 2025, as well as the anticipated expenses we will incur pursuant to the plan' (filed 2025-11-05)
- Removed separate section 'Executive Overview of Results' heading that preceded 'Trends and Uncertainties' (filed 2025-11-05)
- Removed statement about reliance on U.S. federal government operations for clearances/approvals and government shutdown impacts (filed 2025-11-05)
- Removed phrase 'and other results of operations are susceptible' in favor of 'may fluctuate as a result' (filed 2025-11-05)
- Removed reference to 'uncertainty surrounding the durability, scope, and enforceability of existing and future tariff measures' being added as new language (filed 2026-05-06)
- Reworded:
- Changed 'threats or actual or proposed tariffs' to 'uncertainty surrounding the durability, scope, and enforceability of existing and future tariff measures, retaliatory tariffs or protectionist trade measures taken in response to such tariffs' in macroeconomic conditions discussion
- Reordered and rephrased forward-looking statements list to reorganize risk factor topics
- Changed from 'Our strategic priorities focus on four principal pillars for growth' to 'We strive to help our doctor customers move their practices forward... through our continued focus on, and execution of, our strategic growth drivers'
- Changed reference from 'general dental practitioners' to 'General Practitioner dentists' with abbreviation 'GP'
- Changed discussion flow by moving 'Our Strategic Growth Drivers' to its own subsection header rather than appearing within 'Trends and Uncertainties'
- Changed reference from 'Condensed Consolidated Financial Statements' to 'condensed consolidated financial statements' (capitalization)
- Notes:
- Newer filing text appears truncated mid-sentence at end ('For example, we believe that in the beginning of the second quarter of 2025, sales of our pr'), limiting full comparison of that section
- Older filing text also appears incomplete at end ('Many of these factors also impact the availability of certain raw'), preventing full section comparison
Risk Factors
- Added:
- Added new lead sentence in macroeconomic section: 'Global and regional economic conditions have and could in the future materially affect our business, financial condition and results of operations.' (2026-05-06 filing)
- Added phrase 'and adversely impact our gross margin' in tariffs paragraph (2026-05-06 filing)
- Added specification 'international trade disputes' in geopolitical risk title (2026-05-06 filing)
- Removed:
- Removed opening sentence 'Our business, financial condition and results of operations depend on global and regional economic conditions. Inflation, fluctuations in foreign currency exchange rates, changes in consumer confidence and demand, general economic weakness and actual or potential slowdowns or recessions have and could in the future materially affect our business, financial condition and results of operations.' (2025-11-05 filing)
- Removed phrase 'pandemics, wars and military actions' from consumer spending habits list (2025-11-05 filing)
- Removed phrase 'more frequently for orthodontic treatment instead of clear aligners' and replaced with 'to wires and brackets' (2025-11-05 filing)
- Removed reference to 'intraoral scanners and CAD/CAM equipment and software' (2025-11-05 filing)
- Removed phrase 'Increases in the cost of fuel and energy, food, and other essential or discretionary items as well as' before 'higher interest rates' (2025-11-05 filing)
- Removed phrase 'has and may continue to increase' and replaced with 'has and may continue to rise' (2025-11-05 filing)
- Removed phrase 'cost of fuel and energy' being listed separately; consolidated into general cost language (2025-11-05 filing)
- Removed opening phrase 'Our business, financial condition and results of operations could be impacted by' from geopolitical risk title (2025-11-05 filing)
- Removed phrase 'threats or actual imposition of' before tariffs (2025-11-05 filing)
- Removed phrase 'and retaliatory actions' after tariffs and fees (2025-11-05 filing)
- Removed phrase 'and could materially adversely affect our business with our customers and consumers, suppliers, contract manufacturers, commercial intermediaries and other business partners' (2025-11-05 filing)
- Reworded:
- Changed 'revert to wires and brackets' to 'revert to wires and brackets' with different context emphasis (2026-05-06 vs 2025-11-05)
- Changed geopolitical risk section heading from 'Our business, financial condition and results of operations could be impacted by geopolitical events, new, proposed or retaliatory tariffs, trade and international disputes, wars, military actions and terrorism, or major public health crises' to 'Geopolitical events, tariffs and trade policies, and military conflicts have and could in the future materially affect our business, financial condition and results of operations' (restructured focus)
- Changed 'threats or actual imposition of tariffs, customs duties and fees by nations and retaliatory actions' to 'Geopolitical events, wars, military actions, terrorism, or major public health crises' at opening (2026-05-06 filing reordered content)
- Notes:
- The newer filing text appears truncated at the end, cutting off mid-sentence in the tariffs discussion; comparison limited to complete paragraphs
- Some structural reorganization of risk factor content between filings makes precise attribution challenging for minor rewording
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales are on record for ALGN — recent Form 4 activity was compensation-related (awards, option exercises, or tax withholding), not open-market buying or selling.
View full insider trading history → View SEC Form 3/4/5 filingsOnly open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 5 matched disclosures for ALGN from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Institutional ownership (13F)
6 institutional 13F filers reported holding ALGN as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 10,462,346
- Reported value $1,793,559,988
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 2 increased, 4 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
ALGN had 4,202,287 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
ALGN had 5.92% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 3.97 days to cover at the same settlement.
- Reported short interest (shares) 4,202,287
- Short interest (% of shares outstanding) 5.92%
- Prior settlement (shares) 4,825,290
- Reported change -12.91%
- Days to cover (reported) 3.97
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Envista Holdings (NVST)
- Dentsply Sirona (XRAY)
- Straumann Group (STMN.SW)
- Henry Schein (HSIC)
- 3M Company (MMM)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare ALGN vs…
Frequently asked questions
What does Align Technology (ALGN) do?
Align Technology is a global medical device company that designs, manufactures, and markets the Invisalign system of clear aligners and iTero intraoral scanners and services. Its solutions are used by orthodontists and general practitioner dentists to transform and improve the delivery of dental care through digital workflows. The company focuses on the orthodontic and restorative dentistry markets.
What sector is Align Technology (ALGN) in?
Align Technology (ALGN) is classified in the Health Care sector. Its industry is Medical Devices & Supplies. It trades on NASDAQ.
Who are Align Technology's (ALGN) competitors?
Notable peers of Align Technology (ALGN) include Envista Holdings, Dentsply Sirona, Straumann Group, Henry Schein and 3M Company. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in ALGN?
Yes — we hold 5 matched STOCK Act disclosures for ALGN from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Align Technology (ALGN) overbought or oversold right now?
Align Technology (ALGN) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 41, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ALGN come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.